4//SEC Filing
Barrans Russell 4
Accession 0001618835-21-000013
CIK 0001618835other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 8:02 PM ET
Size
8.6 KB
Accession
0001618835-21-000013
Insider Transaction Report
Form 4
Barrans Russell
Chief Commercial Officer
Transactions
- Award
Common Stock
2021-02-03+200,000→ 481,852 total - Award
Stock option (right to buy)
2021-02-03+150,000→ 150,000 totalExercise: $3.25Exp: 2031-02-03→ Common Stock (150,000 underlying)
Holdings
- 279(indirect: By Children)
Common Stock
Footnotes (4)
- [F1]The restricted stock awards will vest based on the Issuer's achievement of certain performance milestones in 2021.
- [F2]The total amount of securities beneficially owned includes 2,800 shares of common stock the reporting person purchased in accordance with the 2019 ESPP based on 85% of the closing stock price on December 15, 2020, the last trading day of the purchase period.
- [F3]These securities were purchased by the reporting person as custodian for one minor child under the Uniform Transfers to Minors Act. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.
- [F4]The shares of common stock exercisable pursuant to the option will vest in a series of forty-eight (48) successive equal monthly installments upon completion of each additional month of service for the Issuer measured from February 3, 2021.
Documents
Issuer
Evofem Biosciences, Inc.
CIK 0001618835
Entity typeother
Related Parties
1- filerCIK 0001726184
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 8:02 PM ET
- Size
- 8.6 KB